跳至主要内容
临床试验/NCT03473444
NCT03473444Unknown不适用

Prevalence of Hyperuricemia in Pakistan

OBS Pakistan1 个研究点 分布在 1 个国家目标入组 1,000 人开始时间: 2018年3月1日最近更新:
适应症

试验速览

阶段
不适用
发起方
OBS Pakistan
入组人数
1,000
试验地点
1
主要终点
Prevalence of Hyperuricemia

研究概览

简要总结

The prevalence of hyperuricemia has rarely been investigated in developing countries Hyperuricemia, or raised serum uric acid (SUA), is the condition closely associated with gout due to the deposition of monosodium urate crystals in peripheral joints and soft tissues. Hyperuricemia is associated with an increased risk for incident hypertension, independent of traditional hypertension risk factors. This risk appears more pronounced in younger individuals and women. Cross-sectional studies show an association of hyperuricemia with the presence of CKD. Insulin resistance plays a potentially key role in the causal relationship between metabolic syndrome, type 2 Diabetes and hyperuricemia. Furthermore, it is likely that hyperuricemia and insulin resistance share a bidirectional causal effect. The rationale of this study is to determine prevalence of hyperuricemia in Pakistan.

详细描述

Informed consent will be obtained from all patients and their attendant coming to clinics. Those who will agree to be part of this study were asked a questionnaire about co-morbidity and symptoms.

Uric acid levels will be assessed by using UASure Blood Uric Acid Monitoring System. Male with uric acid levels greater than 7 mg/dl and female greater than 6 mg/dl were classified as hyperuricemia.

研究设计

研究类型
Observational
观察模型
Ecologic Or Community
时间视角
Cross Sectional

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Informed Consent given

排除标准

  • No Informed consent provided

结局指标

主要结局

Prevalence of Hyperuricemia

时间窗: 4 weeks

To find out the frequency uric acid levels in Pakistani general population

次要结局

未报告次要终点

研究者

发起方
OBS Pakistan
申办方类型
Industry
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验